{
    "nctId": "NCT05850637",
    "briefTitle": "Evaluate the Effectiveness and Toxicity of Adjuvant Ultra-hypofractionated Radiotherapy for Breast Cancer",
    "officialTitle": "Phase II Study to Evaluate the Effectiveness and Toxicity of Adjuvant Ultra-hypofractionated Radiotherapy for the Treatment of Early and Locally Advanced Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Female",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Acute toxicity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Female patient;\n2. Pathological confirmation of invasive breast carcinoma regardless of histological subtype and hormonal profile;\n3. Age greater than or equal to 65 years;\n4. Breast-conserving surgery or mastectomy with or without axillary approach\n5. With or without neoadjuvant or adjuvant systemic treatment\n\nExclusion Criteria:\n\n1. Patients with previous thoracic irradiation;\n2. Patients with indication for bilateral thoracic irradiation;\n3. Patients with breast reconstruction with prosthesis or autologous tissue;\n4. Patients with compromised surgical margins after resection;\n5. pT1-pT2 pN0 patients undergoing radical mastectomy.",
    "sex": "FEMALE",
    "minimumAge": "65 Years",
    "stdAges": "OLDER_ADULT"
}